108858-86-2 Usage
General Description
1-(4-Aminophenyl)cyclopropanecarbonitrile, also known as APC, is a chemical compound with the molecular formula C10H9N. It is a white to off-white solid that is used in the synthesis of pharmaceutical drugs and other organic compounds. APC is a versatile building block for the preparation of various heterocyclic compounds and has been studied for its potential therapeutic applications. It is known for its stable nature, making it a valuable reagent for organic chemistry research. 1-(4-Aminophenyl)cyclopropanecarbonitrile has a cyclopropane ring and a nitrile group, which gives it unique reactivity and potential for various synthetic applications. Overall, 1-(4-Aminophenyl)cyclopropanecarbonitrile is a valuable and versatile chemical compound with potential applications in pharmaceuticals and organic chemistry research.
Check Digit Verification of cas no
The CAS Registry Mumber 108858-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,8,5 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 108858-86:
(8*1)+(7*0)+(6*8)+(5*8)+(4*5)+(3*8)+(2*8)+(1*6)=162
162 % 10 = 2
So 108858-86-2 is a valid CAS Registry Number.
108858-86-2Relevant articles and documents
COMPOUNDS FOR TREATING AND PREVENTING GROWTH HORMONE RECEPTOR-DEPENDENT CONDITIONS
-
, (2021/04/29)
The invention relates to compounds, in particular pyrimidine-2,4-diamines, analogues and salts thereof and pharmaceutical compositions comprising pyrimidine-2,4-diamines analogues and salts thereof for use in the treatment and prevention of a disease, in particular a growth hormone receptor-dependent condition. The invention also relates to methods of using these compounds and compositions to treat physiological dsorders related to the amount or activity of growth hormone. In a particular embodiment, the invention relates to a compound according to formula 1 for use in the treatment or prevention of a disease in a subject
INHIBITORS OF C-FMS KINASE
-
Page/Page column 27, (2008/06/13)
The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, es
